| scholarly article | Q13442814 |
| P50 | author | Francesco Angelico | Q91970179 |
| Domenico Ferro | Q99414156 | ||
| Nicholas Cocomello | Q99414157 | ||
| Alessandra Colantoni | Q99414158 | ||
| Francesco Baratta | Q59206190 | ||
| Maria Del Ben | Q61126339 | ||
| Daniele Pastori | Q42841662 | ||
| P2860 | cites work | Pioglitazone, vitamin E, or placebo for nonalcoholic steatohepatitis | Q24625697 |
| The importance of antioxidants which play the role in cellular response against oxidative/nitrosative stress: current state | Q26741668 | ||
| The Role of NADPH Oxidases (NOXs) in Liver Fibrosis and the Activation of Myofibroblasts | Q26766479 | ||
| Role of the normal gut microbiota | Q26798294 | ||
| Mitochondrial Dysfunction and Signaling in Chronic Liver Diseases | Q90250403 | ||
| Rifaximin in nonalcoholic fatty liver disease: hit multiple targets with a single shot | Q90871088 | ||
| Negative Effects of a High-Fat Diet on Intestinal Permeability: A Review | Q91574444 | ||
| Microbiota and nonalcoholic fatty liver disease/nonalcoholic steatohepatitis (NAFLD/NASH) | Q91621492 | ||
| Dietary vitamin E and C intake is inversely associated with the severity of nonalcoholic fatty liver disease | Q91686083 | ||
| Increased liver localization of lipopolysaccharides in human and experimental non-alcoholic fatty liver disease | Q91750082 | ||
| Intestinal microbiome and NAFLD: molecular insights and therapeutic perspectives | Q92032230 | ||
| Poor Adherence to Mediterranean Diet and Serum Lipopolysaccharide are Associated with Oxidative Stress in Patients with Non-Alcoholic Fatty Liver Disease | Q96345277 | ||
| Silymarin in non-cirrhotics with non-alcoholic steatohepatitis: A randomized, double-blind, placebo controlled trial | Q90178581 | ||
| Role of oxidative stress in the pathogenesis of nonalcoholic fatty liver disease | Q90198073 | ||
| Multiple hits, including oxidative stress, as pathogenesis and treatment target in non-alcoholic steatohepatitis (NASH) | Q27007515 | ||
| Oxidative stress: New insights on the association of non-alcoholic fatty liver disease and atherosclerosis | Q28084150 | ||
| The gut microbiota as an environmental factor that regulates fat storage | Q28131676 | ||
| The role of small intestinal bacterial overgrowth, intestinal permeability, endotoxaemia, and tumour necrosis factor alpha in the pathogenesis of non-alcoholic steatohepatitis | Q28345942 | ||
| Plasma polyphenols and antioxidants, oxidative DNA damage and endothelial function in a diet and wine intervention study in humans | Q28377927 | ||
| Metabolic endotoxemia initiates obesity and insulin resistance | Q29547720 | ||
| The gut microbiota shapes intestinal immune responses during health and disease | Q29547727 | ||
| Systematic review: the epidemiology and natural history of non-alcoholic fatty liver disease and non-alcoholic steatohepatitis in adults | Q29614911 | ||
| Nonalcoholic fatty liver disease | Q29619354 | ||
| Evolution of inflammation in nonalcoholic fatty liver disease: the multiple parallel hits hypothesis | Q29619888 | ||
| What are the risk factors and settings for non-alcoholic fatty liver disease in Asia-Pacific? | Q30361645 | ||
| Bile acids modulate tight junction structure and barrier function of Caco-2 monolayers via EGFR activation. | Q33317737 | ||
| NOX2-generated oxidative stress is associated with severity of ultrasound liver steatosis in patients with non-alcoholic fatty liver disease | Q33583595 | ||
| Oxidative stress as a crucial factor in liver diseases | Q33845484 | ||
| Effects of vitamin E on stroke subtypes: meta-analysis of randomised controlled trials | Q34281575 | ||
| Long-term effect of mediterranean-style diet and calorie restriction on biomarkers of longevity and oxidative stress in overweight men | Q34442801 | ||
| Intestinal microbiota determines development of non-alcoholic fatty liver disease in mice. | Q34496310 | ||
| Rifaximin, a poorly absorbed antibiotic: pharmacology and clinical potential | Q34557101 | ||
| Small intestinal bacteria overgrowth decreases small intestinal motility in the NASH rats | Q34586959 | ||
| EASL-EASD-EASO Clinical Practice Guidelines for the management of non-alcoholic fatty liver disease | Q34676840 | ||
| Redox signaling mediated by the gut microbiota | Q34928547 | ||
| Effect of vitamin E or metformin for treatment of nonalcoholic fatty liver disease in children and adolescents: the TONIC randomized controlled trial | Q35031127 | ||
| Markers of systemic exposures to products of intestinal bacteria in a dietary intervention study | Q35611937 | ||
| High-fat-induced intestinal permeability dysfunction associated with altered fecal bile acids | Q35813480 | ||
| Mediterranean diet supplemented with coenzyme Q10 induces postprandial changes in p53 in response to oxidative DNA damage in elderly subjects. | Q35853626 | ||
| Association of non-alcoholic fatty liver disease with major adverse cardiovascular events: A systematic review and meta-analysis | Q36134867 | ||
| Dietary oxidized n-3 PUFA induce oxidative stress and inflammation: role of intestinal absorption of 4-HHE and reactivity in intestinal cells | Q36213850 | ||
| Metabolic risk factors in mice divergently selected for BMR fed high fat and high carb diets | Q36290308 | ||
| Similar Reduction of Cholesterol-Adjusted Vitamin E Serum Levels in Simple Steatosis and Non-Alcoholic Steatohepatitis | Q36751392 | ||
| Healthy Dietary Patterns and Oxidative Stress as Measured by Fluorescent Oxidation Products in Nurses' Health Study | Q37285954 | ||
| Serum lipopolysaccharide activity is associated with the progression of kidney disease in finnish patients with type 1 diabetes | Q37319187 | ||
| The microenvironment of injured murine gut elicits a local pro-restitutive microbiota. | Q37361083 | ||
| A Mediterranean-style low-glycemic-load diet increases plasma carotenoids and decreases LDL oxidation in women with metabolic syndrome | Q37362418 | ||
| Postprandial serum endotoxin in healthy humans is modulated by dietary fat in a randomized, controlled, cross-over study | Q37396741 | ||
| Oxidative stress: from basic research to clinical application | Q37413739 | ||
| Localization of lipopolysaccharide from Escherichia Coli into human atherosclerotic plaque. | Q52684328 | ||
| Efficacy of rifaximin on circulating endotoxins and cytokines in patients with nonalcoholic fatty liver disease. | Q53479583 | ||
| Intestinal microbiota in patients with nonalcoholic fatty liver disease. | Q54317263 | ||
| Oxidative stress, aging, and diseases. | Q54944008 | ||
| Microbiome-Mediated Effects of the Mediterranean Diet on Inflammation | Q57119534 | ||
| Synbiotic supplementation in nonalcoholic fatty liver disease: a randomized, double-blind, placebo-controlled pilot study | Q57157097 | ||
| NASH Leading Cause of Liver Transplant in Women: Updated Analysis of Indications For Liver Transplant and Ethnic and Gender Variances | Q59359544 | ||
| Mechanisms of NAFLD development and therapeutic strategies. | Q59443140 | ||
| A high-fat meal induces low-grade endotoxemia: evidence of a novel mechanism of postprandial inflammation | Q60998567 | ||
| Dietary Polyphenols Protect Against Oleic Acid-Induced Steatosis in an in Vitro Model of NAFLD by Modulating Lipid Metabolism and Improving Mitochondrial Function | Q64071585 | ||
| A Mediterranean-style, low-glycemic-load diet decreases atherogenic lipoproteins and reduces lipoprotein (a) and oxidized low-density lipoprotein in women with metabolic syndrome | Q84978797 | ||
| Gut-derived lipopolysaccharides increase post-prandial oxidative stress via Nox2 activation in patients with impaired fasting glucose tolerance: effect of extra-virgin olive oil | Q88687570 | ||
| Oxidative Stress and Non-Alcoholic Fatty Liver Disease: Effects of Omega-3 Fatty Acid Supplementation | Q90020289 | ||
| Immunomodulation by dietary long chain omega-3 fatty acids and the potential for adverse health outcomes | Q37552125 | ||
| Serum Cytokeratin-18 Is Associated with NOX2-Generated Oxidative Stress in Patients with Nonalcoholic Fatty Liver | Q37616138 | ||
| A high-fat diet is associated with endotoxemia that originates from the gut | Q37690260 | ||
| Probiotics and Nonalcoholic Fatty liver Disease | Q37708418 | ||
| Probiotics may delay the progression of nonalcoholic fatty liver disease by restoring the gut microbiota structure and improving intestinal endotoxemia | Q37723991 | ||
| Complex links between dietary lipids, endogenous endotoxins and metabolic inflammation. | Q37740254 | ||
| Risk of Cardiovascular Disease in Patients with Nonalcoholic Fatty Liver Disease | Q37794163 | ||
| The role of lipopolysaccharide/toll-like receptor 4 signaling in chronic liver diseases. | Q37834316 | ||
| Role of oxidative stress in the pathogenesis of nonalcoholic steatohepatitis | Q37953770 | ||
| Non-alcoholic fatty liver disease and cardiovascular disease: epidemiological, clinical and pathophysiological evidences | Q38052857 | ||
| Free radical biology for medicine: learning from nonalcoholic fatty liver disease | Q38133184 | ||
| Can α-lipoic acid mitigate progression of aging-related decline caused by oxidative stress? | Q38287160 | ||
| Increased intestinal permeability in obese mice: new evidence in the pathogenesis of nonalcoholic steatohepatitis | Q38308819 | ||
| Effect of a traditional Mediterranean diet on lipoprotein oxidation: a randomized controlled trial. | Q38396625 | ||
| Relation of Vitamin E and Selenium Exposure to Prostate Cancer Risk by Smoking Status: A Review and Meta-Analysis. | Q38562849 | ||
| The Diagnosis and Management of Nonalcoholic Fatty Liver Disease: Practice Guidance from the American Association for the Study of Liver Diseases. | Q38676257 | ||
| The Role of Probiotics in Lipopolysaccharide-Induced Autophagy in Intestinal Epithelial Cells | Q38764163 | ||
| Nonalcoholic Fatty Liver Disease, the Gut Microbiome, and Diet. | Q39180593 | ||
| Eubiotic properties of rifaximin: Disruption of the traditional concepts in gut microbiota modulation | Q39455595 | ||
| Non-alcoholic fatty liver disease and risk of incident cardiovascular disease: A meta-analysis. | Q39745120 | ||
| Chylomicrons promote intestinal absorption of lipopolysaccharides | Q39936075 | ||
| Non-alcoholic fatty liver disease and subclinical atherosclerosis: A comparison of metabolically- versus genetically-driven excess fat hepatic storage | Q40393855 | ||
| Non-alcoholic fatty liver disease and progression of coronary artery calcium score: a retrospective cohort study | Q40593113 | ||
| Postprandial Endotoxemia Linked With Chylomicrons and Lipopolysaccharides Handling in Obese Versus Lean Men: A Lipid Dose-Effect Trial | Q41119627 | ||
| Relation of nonalcoholic fatty liver disease and Framingham Risk Score to flow-mediated dilation in patients with cardiometabolic risk factors | Q41209308 | ||
| Gut Microbiota Promote Angiotensin II-Induced Arterial Hypertension and Vascular Dysfunction. | Q41570815 | ||
| Dietary oil composition differentially modulates intestinal endotoxin transport and postprandial endotoxemia | Q42065353 | ||
| Non-alcoholic fatty liver disease, metabolic syndrome and patatin-like phospholipase domain-containing protein3 gene variants. | Q42209709 | ||
| The role of the gut microbiota in nonalcoholic fatty liver disease | Q42838234 | ||
| Prevalence of and risk factors for nonalcoholic fatty liver disease: the Dionysos nutrition and liver study. | Q43494872 | ||
| Increased intestinal permeability and tight junction alterations in nonalcoholic fatty liver disease. | Q46085888 | ||
| Lifestyle intervention and antioxidant therapy in children with nonalcoholic fatty liver disease: a randomized, controlled trial | Q46553519 | ||
| The therapeutic effect of silymarin in the treatment of nonalcoholic fatty disease: A meta-analysis (PRISMA) of randomized control trials | Q47132791 | ||
| PNPLA3 variant and portal/periportal histological pattern in patients with biopsy-proven non-alcoholic fatty liver disease: a possible role for oxidative stress | Q47139049 | ||
| Gut-Derived Serum Lipopolysaccharide is Associated With Enhanced Risk of Major Adverse Cardiovascular Events in Atrial Fibrillation: Effect of Adherence to Mediterranean Diet. | Q47162918 | ||
| The liver | Q47430653 | ||
| Mediterranean diet: ω-6 and ω-3 fatty acids and diabetes | Q50231573 | ||
| P275 | copyright license | Creative Commons Attribution 4.0 International | Q20007257 |
| P6216 | copyright status | copyrighted | Q50423863 |
| P433 | issue | 9 | |
| P921 | main subject | metabolic dysfunction–associated steatotic liver disease | Q1546498 |
| non-alcoholic fatty liver | Q66299798 | ||
| P577 | publication date | 2020-09-10 | |
| P1433 | published in | Nutrients | Q7070485 |
| P1476 | title | New Insights into the Pathogenesis of Non-Alcoholic Fatty Liver Disease: Gut-Derived Lipopolysaccharides and Oxidative Stress | |
| P478 | volume | 12 |
Search more.